Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplements Containing Stimulants Would Need Preapproval Under Durbin Bill

This article was originally published in The Tan Sheet

Executive Summary

Sen. Charles Schumer (D-N.Y.) is expected to co-sponsor the "Dietary Supplement Safety Act" (S 722), which was introduced March 26 by Sen. Richard Durbin (D-Ill.)
Advertisement

Related Content

Senators Durbin, Hatch To Work Together On AER Plan
Pediatric Supplement Hearing Planned In House; Durbin Slams DSHEA
DSHEA Implementation Action Expected In Second Session Of 108th Congress
House Bill Prohibits Sale Of High-Risk Supplements To Minors
DSHEA “Defense” To Be Supported By Supplement Industry Lobbying Day
NNFA Praises DSHEA Implementation Act, Promotes It As S 722 Alternative
ODS Role As Government Key Advisor Must Be Strengthened – Israelsen
Ephedra Safety Risk Evidence Sufficient For Market Ban – Rep. Waxman
Mandatory Supplement AE Reporting Possible Under Current Law – AHPA
Durbin DSHEA Reform To Focus On Mandatory AERs, Labeling Accuracy

Topics

Advertisement
UsernamePublicRestriction

Register

PS095297

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel